Viewing Study NCT04739150


Ignite Creation Date: 2025-12-24 @ 5:07 PM
Ignite Modification Date: 2026-01-02 @ 10:06 AM
Study NCT ID: NCT04739150
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2022-09-09
First Post: 2021-02-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Expanded Access Program in Belgium to Provide Nintedanib to People With Lung Diseases Called Non-IPF ILDs Who Have no Alternative Treatment Options
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module